Search for: "CIPLA"
Results 41 - 60
of 202
Sort by Relevance
|
Sort by Date
4 Mar 2013, 10:29 pm
Cipla's sale does not aid Bayers' case in any way, particularly since Bayer sued Cipla for infringement. [read post]
28 Feb 2013, 5:11 pm
In fact generics like Cipla have set up their plants in Africa and extending the transition period would attract investments from even more generic companies. [read post]
23 Feb 2013, 10:22 pm
He examines the decision of the Controller in the Sugen v Cipla’s post-grant opposition and points out several junctures at which the Controller has failed to provide necessary authority and has almost as if sworn not to use precedents set by the IPAB to back its conclusions. [read post]
18 Feb 2013, 7:00 pm
Cipla produced a long list of documents which had not been submitted to the Patent Office under Section 8 of the Patent Act and the Patentee argued against this proposition by relying on an interpretation of various precedents of the IPAB and the High Courts. [read post]
18 Feb 2013, 12:46 am
Yusuf Hamied is the Chairman of Cipla and, is also known as the Grand Old Man of the Indian Pharmaceuticals Industry. [read post]
14 Feb 2013, 4:28 pm
Cipla then filed an appeal in the Supreme Court against the High court decision. [read post]
11 Feb 2013, 7:40 pm
Cipla for one continues to manufacture generic equivalents of Sorafenib despite a valid patent held by Bayer. [read post]
29 Jan 2013, 10:44 am
Soon after, Prashant carried another brilliant post revealing the political economy and interplay behind the generic lobbying efforts that might have culminated into such an action by the Indian government and role played by Yusuf Hamied, the head of Cipla. [read post]
15 Jan 2013, 11:49 am
Cipla has always been appealing to the Indian government to modify its intellectual property laws to safeguard Indian consumers from monopoly. [read post]
31 Dec 2012, 11:41 pm
Next in line is a guest post by Madhulika Vishwanathan in the Spicy IP Fellowship Post Series, wherein she has referred to few landmark judgments in 2012 pertaining to the Indian pharmaceutical patent industry, including the grant of compulsory license to Natco Pharma, revocation of the Sunitinib patent owned by Pfizer/Sugen, the Roche-Cipla patent infringement suit, revocation of India’s first pharmaceutical product patent etc. [read post]
31 Dec 2012, 1:52 pm
Cipla patent infringement suit was India’s first pharmaceutical patent litigation in the Post TRIPS era. [read post]
29 Nov 2012, 12:30 pm
Continuing from the last post that discussed background of Tarceva patent and the single judge order rejecting Roche's application for interim injunction to restrain Cipla from manufacturing and selling generic product Erlocip, here we discuss appeal filed by Roche before the divisional bench at the Delhi High Court against the rejection order. [read post]
29 Nov 2012, 12:30 pm
Continuing from the last post that discussed background of Tarceva patent and the single judge order rejecting Roche's application for interim injunction to restrain Cipla from manufacturing and selling generic product Erlocip, here we discuss appeal filed by Roche before the divisional bench at the Delhi High Court against the rejection order. [read post]
17 Nov 2012, 3:48 am
Cipla Ltd. [read post]
17 Nov 2012, 3:48 am
Cipla Ltd. [read post]
2 Nov 2012, 2:38 am
One wonders why pharmaceutical patentees refuse to drop prices, despite being at the receiving end of high court orders (Roche vs Cipla, where Justice Bhat refused to grant an injunction on the grounds of the excessive price differential between the patented drug and the allegedly infringing generic) and compulsory licensing decisions. [read post]
10 Sep 2012, 10:08 pm
Cipla Ltd., 681 F.3d 1283, 1299-1301 (Fed. [read post]
5 Aug 2012, 7:34 am
It should be remembered that companies like Cipla derive almost 40% to 50% of their annual revenues from American and European markets. [read post]
8 Jul 2012, 9:30 pm
South African case law that has referred to European decisions that have caused the UKIPO to summarise the Principles as they have been referred to above include Adcock Ingram v Cipla Medpro (Sabel v Puma), Laugh it off Promotions v SAB (Canon v MGM), Puma v Global Warming (Marca Mode v Adidas) and Cowbell v ICS Holdings (Canon v MGM). [read post]
14 Jun 2012, 10:00 pm
Cipla Limited. [read post]
